752 related articles for article (PubMed ID: 9253354)
1. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
2. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
3. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
4. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
Suzuki S; Tsuchiya A; Hara K; Abe R
Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferative activity of glandular cells in hyperfunctioning parathyroid gland using flow cytometric and immunohistochemical methods.
Xiao-Lin P; Koide N; Kobayashi S; Kobayashi M; Sugenoya A; Iida F; Katsuyama T; Usuda N; Nagata T
World J Surg; 1996; 20(3):361-6; discussion 367. PubMed ID: 8661846
[TBL] [Abstract][Full Text] [Related]
6. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
7. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
8. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid adenomas and glands in normocalcemic hyperparathyroidism. A light microscopic study.
Grimelius L; Ejerblad S; Johansson H; Werner I
Am J Pathol; 1976 Jun; 83(3):475-84. PubMed ID: 937508
[TBL] [Abstract][Full Text] [Related]
11. MIB-1 proliferative index in parathyroid adenoma & hyperplasia.
Karak AK; Sarkar C; Chumber S; Tandon N
Indian J Med Res; 1997 May; 105():235-8. PubMed ID: 9183080
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
[TBL] [Abstract][Full Text] [Related]
13. Peroperative evaluation of parathyroid glands using fat stain on frozen sections. Advantages and limitations.
Farnebo LO; von Unge H
Acta Chir Scand Suppl; 1984; 520():17-24. PubMed ID: 6209877
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
Thomopoulou GE; Tseleni-Balafouta S; Lazaris AC; Koutselini H; Kavantzas N; Davaris PS
Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
16. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings.
Takebayashi S; Hidai H; Chiba T; Takagi Y; Nagatani Y; Matsubara S
J Nucl Med; 1999 Nov; 40(11):1792-7. PubMed ID: 10565772
[TBL] [Abstract][Full Text] [Related]
17. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
19. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
20. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]